Archetypeunverified
Biotech / pharma
Long, binary, capital-consuming development pipeline before any revenue.
What changes about the finance work: Value is almost entirely in probability-weighted future cash flows
Relationships pointing at this node.
changes these tasks
1The task exists in this business archetype but behaves differently. The note is the point of the edge: it must say how it differs, not merely that it does.
There is no revenue to project across most of the horizon. The plan is a probability-weighted pipeline with burn and runway as the operative outputs, and its purpose is to locate the funding milestones rather than to describe a P&L.